Mr. Jones is a partner and co-head of the healthcare sector at Linklaters in London. He has extensive experience in advising leading organisations in the healthcare, pharmaceutical and biotech sectors on intellectual property, regulatory and commercial matters. This includes assisting multinational pharmaceutical companies to co-ordinate international patent disputes ; working with companies and investment banks on M&A and finance transactions ; and identifying and implementing innovative ways for such organisations to make the most of their intellectual property rights.
319
On 11 December 2007, the OFT issued the results of its market study into the distribution of medicines in the UK. The review was initiated after Pfizer announced it would be introducing a Direct to Pharmacy (DTP) distribution model, appointing Unichem as its exclusive Logistics Service (...)
